- OPTIMAL DUAL CUTOFFS OF LIVER STIFFNESS FOR COMPENSATED ADVANCED CHRONIC LIVER DISEASE IN ONTREATMENT PATIENTS WITH CHRONIC HEPATITIS BWu, Xiaoning; Sun, Yameng; Zhou, Jialing; Chen, Yongpeng; Liu, Chenghai; Xing, Huichun; Jiang, Wei; Zhao, Hong; Wang, Bingqiong; Chen, Shuyan; Meng, Tongtong; Ou, Xiaojuan; You, Hong; Jia, JidongMeeting of the American-Association-for-the-Study-of-Liver-Diseases (AASLD), Boston, MA, 2023-11-10 To 2023-11-14.
- LONGER-TERM EXPERIENCE WITH TENOFOVIR ALAFENAMIDE (TAF) IN HBV-INFECTED PATIENTS; CHANGES IN EGFR, FIB4, ALT, AND DNA SUPPRESSIONReddy, K Rajender; Curry, Michael P; Bae, Ho S; Dieterich, Douglas T; Ankoma Sey, Victor; Pan, Calvin Q; Hann, Hie Won L; Tong, Myron J; Kim, W Ray; Kwo, Paul Yien; Frazier, Lynn; Cox, Kimmi; Milligan, Scott; Afdhal, Nezam HAnnual Meeting of the American-Association-for-the-Study-of-Liver-Diseases (AASLD) / Liver Meeting, 2019-11-08 To 2019-11-12.
- Effect of Liuweiwuling tablet on biochemical and virological parameters, and quality of life in patients with hepatitis B virus-related cirrhosisDing, Li; Min, Zhu; Changhui, Zhou; Xiujing, LiuMedicine; analytical reviews of general medicine, neurology, psychiatry, dermatology, and pediatries, 2020, 99(37): e22065.
会议论文
FIBROSIS REGRESSION CONFERS LONGTERM CLINICAL BENEFITS IN PATIENTS ON ANTI- HBV THERAPY: AN EXTENSION ASSESSMENT BY P- I- R SCORE
20阅读
